Загрузка...

DPP-4 inhibitor (sitagliptin)-induced seronegative rheumatoid arthritis

Sitagliptin is a dipeptidyl peptidase-4 inhibitor commonly used in the treatment of type 2 diabetes mellitus for glycaemic control. Concerns have arisen regarding adverse events caused by this drug, particularly concerning arthralgias. Here, we report on a 56-year-old man being treated with sitaglip...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :BMJ Case Rep
Главные авторы: Padron, Simonette, Rogers, Everett, Demory Beckler, Michelle, Kesselman, Marc
Формат: Artigo
Язык:Inglês
Опубликовано: BMJ Publishing Group 2019
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6720914/
https://ncbi.nlm.nih.gov/pubmed/31444259
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2018-228981
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!